Adamax

CognitiveSynthetic Semax analog / nootropic researchExperimental

Adamantane-modified Semax analog researched for neurotrophic signaling and peptide stability. No FDA approval; human PK is not established.

Calculate Dose

For research use only.

Key Facts

CAS: —
Molecular Weight (MW): ≈1033 g/mol
Half-life: Not established; designed for improved stability compared with Semax
Unit: mg
Administration Route: Intranasal or injectable research context; route varies by supplier/protocol
Frequency: Not established
Last updated: 8/23/2026
Targets: Melanocortin pathwaysBDNF-related signaling (proposed)

Overview

Adamantane-modified Semax analog researched for neurotrophic signaling and peptide stability. No FDA approval; human PK is not established.

Protocol

Dosage Range: Not established (research only)
Frequency: Not established
Cycle: Not established (research only; do not self-administer)
Administration Route: Intranasal or injectable research context; route varies by supplier/protocol
Reconstitution Guide: Reconstitute per supplier/lab SOP; commonly bacteriostatic water for lyophilized research peptide

Science

Mechanism of Action

Proposed Semax analog with an adamantane moiety intended to increase lipophilicity and enzymatic stability while retaining melanocortin / neurotrophic pathway activity seen with Semax in preclinical models.

Targets

Melanocortin pathwaysBDNF-related signaling (proposed)

Studies

Semax neurotrophic peptide reviews— Journal/year not available

Benefits

Nootropic and cognitive signaling researchNeuroprotection pathway researchFocus and learning model researchPotential neurotrophic signaling support in experimental contexts